{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:08:27Z","timestamp":1779192507860,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015158","name":"Fondren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015190","name":"Houston Methodist Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015581","name":"Houston Methodist Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ajpath.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T22:34:35Z","timestamp":1604442875000},"page":"90-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti\u2013Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1961-3125","authenticated-orcid":false,"given":"Eric","family":"Salazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-5813","authenticated-orcid":false,"given":"Edward A.","family":"Graviss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-4404","authenticated-orcid":false,"given":"Duc T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-2373","authenticated-orcid":false,"given":"Brian","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bevin V.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd N.","family":"Eagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Picheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shehabeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-5423","authenticated-orcid":false,"given":"David","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Masud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Leveque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-1197","authenticated-orcid":false,"given":"David W.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Gollihar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2020.10.008_bib1","series-title":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)","year":"2020"},{"key":"10.1016\/j.ajpath.2020.10.008_bib2","article-title":"Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience","author":"Joyner","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ajpath.2020.08.001","article-title":"Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality","volume":"190","author":"Salazar","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2020.10.008_bib4","article-title":"Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy","author":"Klassen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib5","article-title":"Relationship between anti-spike protein antibody titers and SARS-CoV-2 in\u00a0vitro virus neutralization in convalescent plasma","author":"Salazar","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib6","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.ajpath.2020.05.014","article-title":"Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma","volume":"190","author":"Salazar","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2020.10.008_bib7","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1172\/JCI141206","article-title":"Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor binding domain IgG correlate with virus neutralization","volume":"130","author":"Salazar","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2020.10.008_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/trf.15843","article-title":"Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design","volume":"60","author":"Barone","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.ajpath.2020.10.008_bib9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","article-title":"Convalescent plasma treatment of severe COVID-19: a matched control study","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ajpath.2020.10.008_bib11","series-title":"Statistical Learning with Sparsity: The Lasso and Generalizations","author":"Hastie","year":"2015"},{"key":"10.1016\/j.ajpath.2020.10.008_bib12","series-title":"Stata Reference Manual: Release 16","author":"Lasso","year":"2020"},{"key":"10.1016\/j.ajpath.2020.10.008_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2020.10.008_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s13063-020-04422-y","article-title":"Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Eckhardt","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ajpath.2020.10.008_bib15","article-title":"Convalescent plasma for COVID-19: a randomized clinical trial","author":"Gharbharan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2020006964","article-title":"Use of convalescent plasma in hospitalized patients with Covid-19: case series","volume":"136","author":"Hegerova","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2020.10.008_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2020.10.008_bib18","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate COVID-19 in India: an open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ajpath.2020.10.008_bib19","article-title":"Convalescent plasma for COVID-19: a multicenter, randomized clinical trial","author":"Avendano-Sola","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib20","article-title":"Early anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: a randomized phase II clinical trial","author":"Balcells","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ajpath.2020.10.008_bib21","first-page":"288","article-title":"Pathophysiology of COVID-19: mechanisms underlying disease severity and progression","volume":"35","author":"Bohn","year":"2020","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ajpath.2020.10.008_bib22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020304892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020304892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:38:16Z","timestamp":1757695096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944020304892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0002944020304892"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.10.008","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.02.20206029","asserted-by":"object"}]},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti\u2013Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}